RxDoctor Payments Data

Aaron Lesser

Family · Albuquerque, NMNPI 1831798677

Payments from drug & device makers

$2,865in general payments, 2019–2025

Across 217 payments — averaging $13.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$357
  • Otsuka America Pharmaceutical, Inc.$112
  • Biohaven Pharmaceutical Holding Company Ltd.$106
  • Novo Nordisk$92
  • Pfizer$92
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,865100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,865 in reported general payments places this provider in the 90th percentile of 1,080 family providers in New Mexico.

See all family providers in New Mexico

Medicare billing

Part B allowed, 2024
$5,734
Medicare patients
22
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide22$21,665
DapagliflozinDapagliflozin Propanediol11$6,458
Albuterol Sulfate HfaAlbuterol Sulfate26$1,264
Lamotrigine13$1,229
Rosuvastatin Calcium16$933
Atorvastatin Calcium72$687
Levothyroxine Sodium56$629
Gabapentin21$456
Lisinopril60$448
Fenofibrate17$388
Bupropion Hcl SrBupropion Hcl35$331
Famotidine17$290
Amitriptyline Hcl15$255
Oxycodone Hcl12$239
Baclofen13$234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$357$21,66522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,080 family providers in New Mexico.

Other family in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →